FinTrust Capital Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-286
Closed -$13K 1234
2021
Q2
$13K Buy
286
+145
+103% +$6.72K ﹤0.01% 876
2021
Q1
$7K Buy
141
+113
+404% +$7.7K ﹤0.01% 981
2020
Q4
$3K Buy
+28
New +$2.35K ﹤0.01% 1005

Other funds holding CELL

FinTrust Capital Advisors's CELL Position: Q3 2021 in Review

FinTrust Capital Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2021, closing a stake of 286 shares — an estimated $13K sold.

FinTrust Capital Advisors first reported a position in CELL in Q4 2020 and held it in 3 quarters. The position peaked at $13K in Q2 2021. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.

  • FinTrust Capital Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • FinTrust Capital Advisors sold 286 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $13K.
  • FinTrust Capital Advisors first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • FinTrust Capital Advisors's PhenomeX Inc. Common Stock position peaked at $13K in Q2 2021.
  • 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.

Based on FinTrust Capital Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.